HIV/AIDS PHARMACY UPDATE: Toxoplasmosis, Polypharmacy/DUR Trends and Journal Club Review


Date: Jun 9, 2016 06:00 PM - 09:00 PM

CE Hours

3.00

CE Units

0.300

Registration closes on Jun 19, 2016 10:00 PM

Activity Type

Knowledge

Target Audience(s)

Pharmacist

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

CPE Monitor: Requirement to Track your CPE
Important new requirement from the Accreditation Council for Pharmacy Education and the National Association of Boards of Pharmacy for all pharmacists and technicians who obtain CPE credit. The CPE Monitor system will securely track all your completed CPE credits in a central system.

https://store.nabp.net/OA_HTML/xxnabpibeGblLogin.jsp 

 

Registration closes on Jun 19, 2016 at 10:00 PM

Registration Closed  

Objectives

  • Discuss the pathophysiology treatment and drug access challenges in toxoplasmosis treatment.
  • Recognize the emerging trends in DUR and Polypharmacy in the population and its application to HIV/AIDS and pharmacy practice.
  • Summarize and evaluate a HIV treatment study using journal club format.
  • Review Toxoplasmosis Encephalitis (TE).
  • Examine the treatment recommendations for toxoplasmosis encephalitis.
  • Describe the ADAP Daraprim(R) (pyrimethamine) Prior Authorization Program.

Speaker(s)/Author(s)

Christopher Keeys, PharmD, BCPS
President, Clinical Pharmacy Associates, Inc

Tammy Dawkins, Pharm.D.
Clinical Pharmacy Associates, Inc.

Activity Number

0010-0000-16-021-L02-P
Date: 06/09/16
Time: 06:00 PM - 09:00 PM

CE Hours

3.00
Registration Closed